Komori
Share Issuance and Disposal4506Sumitomo Pharma Co.,Ltd.Pharmaceuticals

Notice Concerning the Withdrawal of the Shelf Registration for the Issuance of New Shares

The shelf registration for the issuance of new shares filed on 2 March 2026 was withdrawn because the planned offering had been completed. The domestic offering under the shelf registration had already been conducted, with total issue proceeds of ¥41,582,735,152.

Worth reading
47Recurring
Scored from 3 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
41582735152
¥
Wording
Definitive
How definitive the wording is.

Details of issuance or disposal

Offering under the shelf registration for the issuance of new shares (domestic and international offerings)

Intended allottee
As this was a public offering, there was no specific intended allottee. In connection with the over-allotment offering, a third-party allotment to SMBC Nikko Securities Inc. may be conducted on 26 May 2026, for up to 7,695,600 shares.
Total issue value

¥41,582,735,152 (domestic offering)

Offering structure
Overallotment
Shares offered: Not disclosed; maximum number of shares under the third-party allotment: 7,695,600
Details of issuance or disposal
ItemDetails
Type of issuance or disposalOffering under the shelf registration for the issuance of new shares (domestic and international offerings)
Total issue value¥41,582,735,152 (domestic offering)
Intended allotteeAs this was a public offering, there was no specific intended allottee. In connection with the over-allotment offering, a third-party allotment to SMBC Nikko Securities Inc. may be conducted on 26 May 2026, for up to 7,695,600 shares.
OverallotmentShares offered: Not disclosed; maximum number of shares under the third-party allotment: 7,695,600
Items this document does not state (24)
Number of shares to be issued or disposed ofIssue price and disposal priceAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyDilution RateTotal number of issued sharesBasis for determining the amount to be paidExercise priceExercise periodNumber of Stock Acquisition RightsTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offeringImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The planned offering of new shares under the shelf registration had been completed.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Notice Concerning the Withdrawal of the Shelf Registration for the Issuance of New Shares | Sumitomo Pharma Co.,Ltd. (4506) timely disclosure | Komori